FDA Drug recall D-1862-2019
Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 1…
- FDA Drug
- Class II
- terminated
- Published 2019-09-25
On 2019-09-25 the FDA classified a Class II recall of Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 1… by Torrent Pharma, citing failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1862-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-09-06 |
| Published | 2019-09-25 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Torrent Pharma |
| Distribution | US |
Product
Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.
Reason
Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
Identifiers
| ndc | 13668-453-30 |
|---|---|
| ndc | 13668-453-01 |
| ndc | 13668-462-30 |
| ndc | 13668-462-01 |
| code_info | Lot #: BFE2E003, Exp 08/31/2020 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1862-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.